A rare cause of pneumonia in an immunocompromised patient

Andrea Renda, Alessio Trombetta, Andrea Zappalà, Alfio Proietto, Antonio Faiello, Rosalba Relo, Federica Lo Bello, Paola Maria Cutroneo, Antonio Ieni, Giuseppe Mancuso, Guido Fadda, Francesco Monaco

Abstract


We present the case of a 69-year-old immunocompromised man admitted to our Pulmonology Unit for acute respiratory failure secondary to pulmonary mucormycosis infiltrating and occluding the left main bronchus and pulmonary artery. The patient was treated with liposomal amphotericin B, but developed severe hypokalaemia and anaemia. Despite the treatment, after 63 days, the patient died for cardiorespiratory arrest.


Keywords


acute respiratory failure, mucormycosis, immunocompromised, hypokalaemia, anaemia

Full Text:

PDF

References


1.Steinbrink, J.M., Miceli, M.H. (2021). Mucormycosis. Infect Dis Clin North Am. 35, 435-452. doi: 10.1016/j.idc.2021.03.009.

2. Cornely, O.A., Alastruey-Izquierdo, A., Arenz, D., Chen, S.C.A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H.E., Lagrou, K., Lewis, R.E., Mellinghoff, S.C., Mer, M., Pana, Z.D., Seidel, D., Sheppard, D.C., Wahba, R., Akova, M., Alanio, A., Al-Hatmi, A.M.S., Arikan-Akdagli, S., Badali, H., Ben-Ami, R., Bonifaz, A., Bretagne, S., Castagnola, E., Chayakulkeeree, M., Colombo, A.L., Corzo-León, D.E., Drgona, L., Groll, A.H., Guinea, J., Heussel, C.P., Ibrahim, A.S., Kanj, S.S., Klimko, N., Lackner, M., Lamoth, F., Lanternier, F., Lass-Floerl, C., Lee, D.G., Lehrnbecher, T., Lmimouni, B.E., Mares, M., Maschmeyer, G., Meis, J.F., Meletiadis, J., Morrissey, C.O., Nucci, M., Oladele, R., Pagano, L., Pasqualotto, A., Patel, A., Racil, Z., Richardson, M., Roilides, E., Ruhnke, M., Seyedmousavi, S., Sidharthan, N., Singh, N., Sinko, J., Skiada, A., Slavin, M., Soman, R., Spellberg, B., Steinbach, W., Tan, B.H., Ullmann, A.J., Vehreschild, J.J., Vehreschild, M.J.G.T., Walsh, T.J., White, P.L., Wiederhold, N.P., Zaoutis, T., Chakrabarti, A., Mucormycosis ECMM MSG Global Guideline Writing Group. (2019). Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 19, e405-e421. doi: 10.1016/S1473-3099(19)30312-3

3. Egger, M., Hoenigl, M., Thompson, G.R. 3rd, Carvalho, A., Jenks, J.D. (2022). Let's talk about sex characteristics-As a risk factor for invasive fungal diseases. Mycoses. 65, 599-612. doi: 10.1111/myc.13449.

4. Agrawal, R., Yeldandi, A., Savas, H., Parekh, N.D., Lombardi, P.J., Hart, E.M. (2020). Pulmonary Mucormycosis: Risk Factors, Radiologic Findings, and Pathologic Correlation. Radiographics. 40, 656-666. doi: 10.1148/rg.2020190156.

5. Loo, A.S., Muhsin, S.A., Walsh, T.J. (2013). Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B. Expert Opin Drug Saf. 12, 881-895. doi: 10.1517/14740338.2013.827168.

6. Garg, M., Prabhakar, N., Muthu, V., Farookh, S., Kaur, H., Suri, V., Agarwal, R. (2022). CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review. Radiology. 302, 214-217. doi: 10.1148/radiol.2021211583.




DOI: https://doi.org/10.13129/1828-6550/APMB.111.2.2023.CCS4

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Andrea Renda, Alessio Trombetta, Andrea Zappalà, Alfio Proietto, Antonio Faiello, Rosalba Relo, Federica Lo Bello, Paola Maria Cutroneo, Antonio Ieni, Giuseppe Mancuso, Guido Fadda, Francesco Monaco

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.